The influence of drugs affecting lipids on  atherosclerosis.
D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology*; D001796:Blood Protein Disorders / Q000188:drug therapy; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D048909:Diabetes Complications; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D005260:Female; D005947:Glucose; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy*; D007328:Insulin / Q000276:immunology; D008074:Lipoproteins / Q000097:blood; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D013974:Thyroxine / Q000031:analogs & derivatives / Q000627:therapeutic use
D004040:Dietary Carbohydrates; D007328:Insulin; D008074:Lipoproteins; D009539:Nicotinic Acids; D002994:Clofibrate; D005947:Glucose; D013974:Thyroxine